Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Martin Nicol , Mathilde Baudet , Alain Cohen-Solal Added: 3 years ago
Advances in the early detection and treatment of cancer have improved overall survival in cancer patients. Nevertheless, cardiovascular diseases appear as the major cause of morbidity and mortality among cancer survivors.1 Left ventricular (LV) dysfunction and/or heart failure are the most common cardiovascular complications after administration of chemotherapies. The term ‘cardiotoxicity’ is… View more
Author(s): Angela Hoye , Rodney H Stables , Anthony Mathur , et al Added: 1 year ago
BCIS ACI 2023­ – Dr Angela Hoye (Hull & East Yorkshire Hospitals, UK), is joined by Dr Rod Stables (Liverpool Heart and Chest Hospital, UK), Dr Anthony Mathur (Barts Health NHS Trust, UK) and Dr Sen Devadathan (Royal Cornwall Hospitals NHS Trust, UK) to have a critical discussion on the BCIS-REVIVED trial and what it means for patients with ischemic left ventricular dysfunction in 2023. Data… View more
Author(s): Kenan Yalta , Mustafa Yılmaztepe , Cafer Zorkun Added: 3 years ago
In the past decades, takotsubo cardiomyopathy (TTC) has emerged as a specific form of acute and transient myocardial disease, predominantly affecting postmenopausal women in the clinical setting.1–4 In general, myocardial involvement in this setting appears to harbour a regional pattern particularly extending beyond the territory of a single coronary artery (and usually without concomitant… View more
Author(s): John Pepper Added: 3 years ago
The most common cause of heart failure with reduced ejection fraction (HFrEF) in the industrialised world is coronary heart disease.1 Patients with an ischaemic aetiology of left ventricular systolic dysfunction have significantly higher mortality rates than those with non-ischaemic aetiologies.2 This more aggressive course represents the convergence of ischaemic myocardial fibrosis and… View more
Research Area(s) / Expertise:

Cardio-oncology

Heart Failure

Job title: Assistant Professor
Dr Giselle Melendez is anAssistant Professor atWake Forest University School of Medicine, Winston-Salem, US.Commencing her scientific career at the University of South Carolina School of Medicine, Dr. Melendez focused on molecular mediators of myocardial extracellular matrix remodeling and heart failure. Notably, her research uncovered vital insights into inflammatory cytokines TNF-α, IL-6, and… View more
Research Area(s) / Expertise: Job title: Founder and Medical Director of the Heart Failure Unit
Prof Ken McDonald is the founder and Medical Director of the Heart Failure Unit at St Vincent's University Hospital, Dublin, and is presently the National Clinical Lead for Heart Failure in Ireland. He is also the Principal Investigator of the Chronic Cardiovascular Disease Management Group. Prof McDonald has published more than 100 peer reviewed articles. In addition to the clinical services… View more
Job title: Professor of Heart Failure and Consultant Cardiologist
Theresa McDonagh is a consultant cardiologist at King's College London. Her research interests are in clinical heart failure,in particular the epidemiology of heart failure and left ventricular dysfunction and the role of biomarkers. Prof McDonagh is currently chair of the Clinical Section of the Heart Failure Association of the ESC and clinical lead for the National Heart Failure Audit. Dr… View more
Research Area(s) / Expertise: Job title: Professor of Medicine and Director of Cardiomyopathy Program
DrLynne Stevenson is aProfessor of Medicine and Director of Cardiomyopathy Program atVanderbilt University Medical Center, Nashville, US. Herresearch experience includes acute and ambulatory hemodynamic monitoring, exercise physiology, heart failure hospitalisations and the interface of arrhythmias and sudden death risk with left ventricular dysfunction. View more
Author(s): Demilade Adedinsewo Added: 5 months ago
AHA 23 - We are joined by Dr Demilade Adedinsewo (Mayo Clinic, US) to discuss the findings from a study investigating the effectiveness of an artificial intelligence-enabled ECG (AI-ECG) for cardiomyopathy detection in an obstetric population.In the intervention arm, the digital stethoscope correctly identified 92% of those with ejection fraction <50% and 100% of those with ejection fraction … View more
Prof Divaka Perera is a Professor of Interventional Cardiology in the School of Cardiovascular Medicine & Sciences and an Honorary Cardiologist at Guy’s and St Thomas’ Hospital. He graduated in medicine from Cambridge University, undertook cardiology specialist training in London and Sussex and received a Clinical Senior Lectureship Award from the Higher Education Funding Council for England in… View more